Nucelion Therapeutics, VeGen Bio Partner on CAR-T Therapy The Story: Nucelion Therapeutics and VeGen Bio have partnered to transfer technology and manufacture VL-2511, a Phase II dual-target CAR-T the...
Peptris Technologies Secures ₹86 Crore for AI-Discovered Drug Candidates The Story: Peptris Technologies has secured ₹86 crore under India’s RDI Fund to advance four AI-discovered drug candidates thro...
AstraZeneca’s Camizestrant Clears India’s SEC Review The Story: AstraZeneca’s camizestrant has received a positive SEC recommendation in India for HR-positive, HER2-negative advanced breast cancer wit...
Akums Gets CDSCO Nod for Colchicine The Story:Sanofi Healthcare India has acquired a 15.19% stake in Sanofi India for ₹1,068.2 crore, with the shares transferred internally from fellow promoter entity...
Fredun Pharma Acquires 26% Stake in Goodman Vetcare The Story:Fredun Pharmaceuticals has acquired a 26% stake in Goodman Vetcare at a valuation of ₹300 crore to expand its presence in India’s animal h...
Dr. Reddy’s Signs License Deal for Once-Yearly Lenacapavir The Story:Dr. Reddy’s has signed a royalty-free, non-exclusive license agreement with Gilead Sciences for investigational once-yearly lenacap...
ChrysCapital to Acquire Linux Laboratories Stake The Story: ChrysCapital is set to acquire a 20–25% stake in CNS-focused Linux Laboratories for around ₹600 crore, with Tata Capital Healthcare Fund II ...
Novonesis to Invest €600 Million in India The Story: Novonesis will invest €600 million to expand its Patalganga site and build an advanced enzyme production facility, expected to be operational by 20...
Dr. Reddy’s Gets Abatacept Biosimilar Approval The Story: Dr. Reddy’s has received CDSCO approval for its abatacept biosimilar in India for rheumatoid arthritis and psoriatic arthritis. The Take: The ...
Mankind Pharma Inks Deal for Two Insulin Analogues The Story: Mankind Pharma has entered an exclusive agreement with Chongqing Chenan to commercialize Insulin Degludec and Insulin Degludec + Aspart in...
